Clemastine Fumarate
4 NDCs across 3 manufacturers|4 Generic,0 Brand
Clemastine Fumarate is used to treat angioedema, rhinitis, allergic, perennial and urticaria, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 31, 1992. In 2024, Medicare Part D spent $20 million on Clemastine Fumarate across 7,234 claims for 2,104 beneficiaries.
Clemastine Fumarate is available as 4 NDCs from 3 manufacturers (4 generic, 0 brand), with NADAC prices from $3.18 to $3.36 per EA — a 6% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
4G / 0B
Manufacturers
3
competing in market
Price Spread
$3.18 – $3.36
per EA, 3 of 4 NDCs
7d Activity
avg -0.6% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Genus Lifesciences Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing CLEMASTINE FUMARATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CLEMASTINE 0.5 MG/5 ML SYRUP | $5.4917 per ML | -0.13% |
CLEMASTINE FUM 2.68 MG TABLET | $3.3560 per EA | — |
CLEMASTINE FUM 2.68 MG TABLET | $3.1775 per EA | -0.82% |
CLEMSZA 2.68 MG TABLET | $3.1775 per EA | -0.82% |
Frequently Asked Questions
What is Clemastine Fumarate used to treat?
Clemastine Fumarate is used to treat angioedema, rhinitis, allergic, perennial and urticaria, per the National Library of Medicine's MED-RT classification.
When did Clemastine Fumarate become available as a generic?
FDA approved the first generic Clemastine Fumarate (ANDA) on Jan 31, 1992.
How much does Medicare spend on Clemastine Fumarate?
In 2024, Medicare Part D spent $20 million on Clemastine Fumarate across 7,234 claims for 2,104 beneficiaries.
How many Clemastine Fumarate products are on the market?
The Clemastine Fumarate drug market contains 4 NDCs from 3 manufacturers — 4 generic and 0 brand products.
What is the price range for Clemastine Fumarate?
NADAC reference prices for Clemastine Fumarate range from $3.1775 to $3.3560 per EA — a 6% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Clemastine Fumarate?
3 manufacturers list Clemastine Fumarate in NADAC. Ranked by number of NDCs, the largest are Genus Lifesciences Inc. (2), Teva Pharmaceuticals USA Inc. (1), IPG Pharmaceuticals, Inc. (1).
How has the price of Clemastine Fumarate changed recently?
Over the past 7 days, 0 Clemastine Fumarate NDCs rose and 3 fell, with a market-wide average change of -0.6%.